XML 55 R39.htm IDEA: XBRL DOCUMENT v3.25.1
Derivative Instruments (Tables)
3 Months Ended
Mar. 31, 2025
Derivative Instruments  
Schedule of effective portion of gains and losses on derivative instruments

The effect of these net investment hedges on accumulated other comprehensive loss and the condensed consolidated income statements for the three months ended March 31, 2025 and 2024 was as follows (in thousands):

Three Months Ended March 31, 

2025

    

2024

Cross-currency interest rate swaps (included component) (1)

$

(92,339)

$

(52,030)

Cross-currency interest rate swaps (excluded component) (2)

28,406

5,649

Total

$

(63,933)

$

(46,381)

Location of

Three Months Ended March 31, 

gain or (loss)

2025

    

2024

Cross-currency interest rate swaps (excluded component) (2)

Interest expense

$

7,599

$

6,103

(1)Included component represents foreign exchange spot rates.
(2)Excluded component represents cross-currency basis spread and interest rates.
Schedule of effect of cash flow hedges on accumulated other comprehensive income and the consolidated income statements

The effect of these cash flow hedges on accumulated other comprehensive income and the condensed consolidated income statements for the three months ended March 31, 2025 and 2024 was as follows (in thousands):

Three Months Ended March 31, 

2025

    

2024

Interest rate swaps

$

8,127

$

(12,324)

Location of

Three Months Ended March 31, 

gain or (loss)

2025

    

2024

Interest rate swaps

Interest expense

$

1,058

$

4,227

Schedule of fair value of derivative instruments in Balance sheets

The subsequent table presents the fair value of derivative instruments recognized in our condensed consolidated balance sheets as of March 31, 2025 and December 31, 2024 (in thousands):

March 31, 2025

December 31, 2024

    

Assets (1)

    

Liabilities (2)

    

Assets (1)

    

Liabilities (2)

Cross-currency interest rate swaps

$

16,157

$

122,805

$

32,883

$

75,597

Interest rate swaps

5,735

18,109

6,130

11,253

$

21,892

$

140,914

$

39,013

$

86,850

(1)As presented in our condensed consolidated balance sheets within Other assets.
(2)As presented in our condensed consolidated balance sheets within Accounts payable and other accrued liabilities.